115 related articles for article (PubMed ID: 21183370)
61. Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial.
Holbech JV; Bach FW; Finnerup NB; Brøsen K; Jensen TS; Sindrup SH
Pain; 2015 May; 156(5):958-966. PubMed ID: 25719617
[TBL] [Abstract][Full Text] [Related]
62. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy.
Simpson DM; Olney R; McArthur JC; Khan A; Godbold J; Ebel-Frommer K
Neurology; 2000 Jun; 54(11):2115-9. PubMed ID: 10851374
[TBL] [Abstract][Full Text] [Related]
63. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.
Sindrup SH; Andersen G; Madsen C; Smith T; Brøsen K; Jensen TS
Pain; 1999 Oct; 83(1):85-90. PubMed ID: 10506675
[TBL] [Abstract][Full Text] [Related]
64. The Impact of Serum Drug Concentration on the Efficacy of Imipramine, Pregabalin, and their Combination in Painful Polyneuropathy.
Sindrup SH; Holbech JV; Bach FW; Finnerup NB; Brøsen K; Jensen TS
Clin J Pain; 2017 Dec; 33(12):1047-1052. PubMed ID: 28272120
[TBL] [Abstract][Full Text] [Related]
65. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.
Ellis RJ; Toperoff W; Vaida F; van den Brande G; Gonzales J; Gouaux B; Bentley H; Atkinson JH
Neuropsychopharmacology; 2009 Feb; 34(3):672-80. PubMed ID: 18688212
[TBL] [Abstract][Full Text] [Related]
66. Pronociceptive pain modulation in patients with painful chemotherapy-induced polyneuropathy.
Nahman-Averbuch H; Yarnitsky D; Granovsky Y; Sprecher E; Steiner M; Tzuk-Shina T; Pud D
J Pain Symptom Manage; 2011 Aug; 42(2):229-38. PubMed ID: 21458224
[TBL] [Abstract][Full Text] [Related]
67. Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.
Woods SW; Saksa JR; Baker CB; Cohen SJ; Tek C
J Clin Psychiatry; 2008 Apr; 69(4):546-54. PubMed ID: 18312060
[TBL] [Abstract][Full Text] [Related]
68. Pain phenotype as a predictor for drug response in painful polyneuropathy-a retrospective analysis of data from controlled clinical trials.
Holbech JV; Bach FW; Finnerup NB; Jensen TS; Sindrup SH
Pain; 2016 Jun; 157(6):1305-1313. PubMed ID: 27007067
[TBL] [Abstract][Full Text] [Related]
69. Lack of efficacy of levetiracetam in oromandibular and cranial dystonia.
Park JE; Srivanitchapoom P; Maurer CW; Mathew P; Sackett J; Paine R; Ramos VL; Hallett M
Acta Neurol Scand; 2017 Aug; 136(2):103-108. PubMed ID: 27808417
[TBL] [Abstract][Full Text] [Related]
70. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.
Clifford DB; Simpson DM; Brown S; Moyle G; Brew BJ; Conway B; Tobias JK; Vanhove GF;
J Acquir Immune Defic Syndr; 2012 Feb; 59(2):126-33. PubMed ID: 22067661
[TBL] [Abstract][Full Text] [Related]
71. Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study.
Solaro C; de Sire A; Messmer Uccelli M; Mueller M; Bergamaschi R; Gasperini C; Restivo DA; Stabile MR; Patti F
Eur J Neurol; 2020 Nov; 27(11):2209-2216. PubMed ID: 32558044
[TBL] [Abstract][Full Text] [Related]
72. Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial.
Mattes JA
J Clin Psychiatry; 2008 Feb; 69(2):310-5. PubMed ID: 18232724
[TBL] [Abstract][Full Text] [Related]
73. Levetiracetam in stiff-person syndrome.
Sechi G; Barrocu M; Piluzza MG; Cocco GA; Deiana GA; Sau GF
J Neurol; 2008 Nov; 255(11):1721-5. PubMed ID: 18769864
[TBL] [Abstract][Full Text] [Related]
74. Levetiracetam as migraine prophylaxis.
Cochran JW
Clin J Pain; 2004; 20(3):198-9. PubMed ID: 15100599
[No Abstract] [Full Text] [Related]
75. Impact of levetiracetam on mood and cognition during prednisone therapy.
Brown ES; Frol AB; Khan DA; Larkin GL; Bret ME
Eur Psychiatry; 2007 Oct; 22(7):448-52. PubMed ID: 17766093
[TBL] [Abstract][Full Text] [Related]
76. Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial.
Roeske MJ; McHugo M; Rogers B; Armstrong K; Avery S; Donahue M; Heckers S
Neuropsychopharmacology; 2024 Mar; 49(4):681-689. PubMed ID: 37833590
[TBL] [Abstract][Full Text] [Related]
77. The Role of Levetiracetam in Treating Chronic Neuropathic Pain Symptoms.
Crawford-Faucher A; Huijon RM
Am Fam Physician; 2015 Jul; 92(1):23-4. PubMed ID: 26132123
[No Abstract] [Full Text] [Related]
78. Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia.
Rowbotham MC; Manville NS; Ren J
Neurology; 2003 Sep; 61(6):866-7. PubMed ID: 14504347
[No Abstract] [Full Text] [Related]
79. Levetiracetam in the treatment of neuropathic pain: three case studies.
Price MJ
Clin J Pain; 2004; 20(1):33-6. PubMed ID: 14668654
[TBL] [Abstract][Full Text] [Related]
80. The beneficial effects of levetiracetam on polyneuropathy in the early stage of sepsis in rats: electrophysiological and biochemical evidence.
Erbaş O; Yeniel AÖ; Akdemir A; Ergenoğlu AM; Yilmaz M; Taskiran D; Peker G
J Invest Surg; 2013 Dec; 26(6):312-8. PubMed ID: 23957613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
